Bg pattern

TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Tiorfan Infants 10 mg Granules for Oral Suspension

racecadotril

Read the entire package leaflet carefully before starting to take the medicine.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed to your child and should not be given to others, even if they have the same symptoms as your child, as it may harm them.
  • If your child experiences side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What is Tiorfan and what is it used for
  2. What you need to know before taking Tiorfan
  3. How to take Tiorfan
  4. Possible side effects
  5. Storage of Tiorfan
  6. Package Contents and Additional Information

1. What is Tiorfan and what is it used for

Tiorfan is a medicine for the treatment of diarrhea.

Tiorfan is used to treat the symptoms of acute diarrhea in children over 3 months. It should be used along with plenty of fluid intake and usual dietary measures, when these measures alone are insufficient to control diarrhea, and when the causes of diarrhea cannot be treated.

If causal treatment is possible, racecadotril may be administered as complementary treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Tiorfan

Do not use Tiorfan

  • If your child is allergic to racecadotril or any of the other ingredients of Tiorfan (listed in section 6).
  • If your doctor has told you that your child has intolerance to some sugars, ask your doctor before giving Tiorfan to your child.
  • If your child has ever developed a severe skin rash, skin peeling, blisters, and/or sores in the mouth after taking racecadotril.

Warnings and Precautions

Consult your doctor or pharmacist before starting to give Tiorfan to your child if:

  • your child is under 3 months old,
  • there is blood or pus in your child's stool and if they have a fever. The cause of their diarrhea may be a bacterial infection that needs to be treated by your doctor,
  • your child suffers from chronic diarrhea or diarrhea caused by antibiotics,
  • your child suffers from prolonged or uncontrolled vomiting,
  • your child has kidney disease or insufficient liver function,
  • your child has diabetes (see "Important information about some of the ingredients of Tiorfan").

Racecadotril, the active ingredient of Tiorfan, may cause an allergic reaction called angioedema, which can cause swelling of the face, lips, throat, or tongue. If your child experiences these side effects, stop treatment immediately and contact your doctor. Swelling can occur at any time during treatment with this product.

The concomitant use of this product and some other medicines may increase the risk of angioedema (see "Other medicines and Tiorfan").

Skin reactions have been reported with the use of this product. In most cases, they are mild and do not require treatment. In some cases, severe skin reactions may occur. In these cases, treatment should be stopped immediately and the child should not be treated with racecadotril again.

Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with treatment with racecadotril. Discontinue the use of racecadotril and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.

Using Tiorfan with other medicines

Tell your doctor if your child is using, has recently used, or may need to use any other medicine.

Especially tell your doctor if your child is using any of the following medicines:

  • ACE inhibitor (e.g., perindopril or ramipril) used to lower blood pressure or treat heart failure.
  • Sacubitril, used to treat heart failure.
  • Some immunosuppressants (e.g., sirolimus or everolimus).
  • Some antidiabetics (e.g., sitagliptina or vildagliptina).
  • Estramustine, used to treat cancer.
  • Alteplase, used to treat blood clots.

Pregnancy and Breastfeeding

The use of Tiorfan is not recommended during pregnancy and breastfeeding.

Consult your doctor or pharmacist before using this medicine.

Driving and Using Machines

Tiorfan has little or no effect on the ability to drive or use machines.

Tiorfan contains sucrose

Tiorfan contains approximately 1 g of sucrose per sachet.

If your doctor has told you that your child has intolerance to some sugars, ask your doctor before giving Tiorfan to your child.

In babies with diabetes, if your doctor has prescribed more than 5 sachets of Tiorfan per day to your child (which corresponds to more than 5 g of sucrose), this should be taken into account in the child's total daily sugar intake.

3. How to take Tiorfan

Follow the instructions for administering Tiorfan exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

Tiorfan is presented in granule form.

The granules can be added to food or mixed in a glass of water or in the baby bottle. Mix well and give to your child immediately.

The recommended daily dose depends on your child's weight: 1.5 mg/kg per dose (corresponding to 1-2 sachets), three times a day at regular intervals.

In children up to 9 kg in weight: one sachet per dose.

In children from 9 to 13 kg in weight: two sachets per dose.

Your doctor will indicate the duration of treatment with Tiorfan. Treatment should be continued until two normal stools are produced, without exceeding 7 days.

To compensate for the loss of fluid due to your child's diarrhea, this medicine should be used along with adequate fluid and electrolyte replacement. The best replacement of fluids and salts is achieved with an oral rehydration solution (please ask your doctor or pharmacist if you are unsure).

If you give more Tiorfan than you should

If your child has taken more Tiorfan than they should, contact your doctor or pharmacist immediately.

If you forget to give Tiorfan

Do not give a double dose to your child to make up for a forgotten dose. Simply continue with the treatment.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop administering Tiorfan to your child and contact a doctor immediately if your child experiences symptoms of angioedema, such as:

  • swelling of the face, tongue, or pharynx
  • difficulty swallowing
  • hives and difficulty breathing

Discontinue the use of racecadotril and seek medical attention immediately if you notice any of the following symptoms:

  • Widespread skin rash, high body temperature, and enlarged lymph nodes (DRESS syndrome)
  • Difficulty breathing, swelling, dizziness, rapid heartbeat, sweating, and feeling of loss of consciousness, symptoms of a severe and sudden allergic reaction.

The following side effects have been reported:

Uncommon (may affect up to 1 in 100 people):

tonsillitis (inflammation of the tonsils), rash, and erythema (redness of the skin).

Frequency not known (frequency cannot be estimated from the available data):

erythema multiforme (red lesions on the extremities and inside the mouth), tongue swelling, facial swelling, lip swelling, eyelid swelling, urticaria, erythema nodosum (inflammation in the form of lumps under the skin), papular rash (rash on the skin with small, hard, and raised lesions), prurigo (lesions on the skin with itching), and pruritus (generalized itching).

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Tiorfan

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the sachet and carton after EXP. The expiry date is the last day of the month indicated.

No special storage conditions are required.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Tiorfan

The active substance is racecadotril. Each sachet contains 10 mg of racecadotril.

The other ingredients are:

sucrose,

colloidal anhydrous silica,

30% polyacrylate dispersion,

apricot flavor.

Appearance of Tiorfan and Package Contents

Tiorfan is presented in granule form for oral suspension in sachets.

Each pack contains 10, 16, 20, 30, 50, or 100 sachets (100 sachets only as a clinical pack).

Not all pack sizes may be marketed.

Marketing Authorization Holder

BIOPROJET-FERRER, S.L.

Gran Vía Carlos III, 94

08028 Barcelona (Spain)

Manufacturer

FERRER INTERNACIONAL, S.A.

Joan Buscallà 1-9

08173 Sant Cugat del Vallès, Barcelona (Spain)

or

SOPHARTEX,

21 rue de Pressoir,

28500 Vernouillet (France)

This medicine is authorized in the Member States of the European Economic Area under the following names:

GERMANY: Tiorfan

PORTUGAL: Tiorfan

GREECE: Hidrasec

ITALY: Tiorfix

AUSTRIA: Hidrasec

BELGIUM: Tiorfast

CZECH REPUBLIC: Hidrasec

DENMARK: Hidrasec

ESTONIA: Hidrasec

FINLAND: Hidrasec

HUNGARY: Hidrasec

IRELAND: Hidrasec

LATVIA: Hidrasec

LITHUANIA: Hidrasec

LUXEMBOURG: Tiorfast

NETHERLANDS: Tiorfan

POLAND: Hidrasec

SLOVAKIA: Hidrasec

SLOVENIA: Hidrasec

SWEDEN: Hidrasec

UNITED KINGDOM: Hidrasec

Date of the last revision of this package leaflet: 24-11-2024

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es.

Online doctors for TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES

Discuss questions about TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES?
TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES?
The active ingredient in TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES is racecadotril. This information helps identify medicines with the same composition but different brand names.
Who manufactures TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES?
TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES is manufactured by Bioprojet Ferrer. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TIORFAN LACTANTES 10 mg ORAL SUSPENSION GRANULES?
Other medicines with the same active substance (racecadotril) include HIDRASEC 100 mg HARD CAPSULES, TIORFAN 100 mg HARD CAPSULES, TIORFAN INFANTIL 4 mg/mL ORAL SUSPENSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media